The invention relates to a
tigecycline freeze-dried
powder injection, which consists of
tigecycline,
dextran,
sodium sulfite and
sodium citrate according to the following weight proportion: 10 portions of the
tigecycline, 10 to 90 portions of the
dextran, 0.1 to 3 portions of
anhydrous sodium sulfite, and 0.1 to 3 portions of the
sodium citrate. The pH value of the tigecycline freeze-dried
powder injection is between 7.0 and 9.0. The preparing process comprises the following steps: firstly, dissolving the
dextran by 80 percent of water for injection; secondly, adding the
sodium citrate and the
anhydrous sodium sulfate into the mixture after cooling; thirdly, adding the tigecycline into the mixture after dissolving and evenly stirring the
sodium citrate and the
anhydrous sodium sulfate, and mixing the mixture evenly; and fourthly, regulating the pH to between 7.0 and 9.0, adding a needle
activated carbon into the mixture, stirring and adsorbing the mixture, removing the
activated carbon from the mixture, and fixing the capacity. The solution is filtered through two
microporous membranes and then are filled in a cillin
bottle, and the tigecycline freeze-dried
powder injection is obtained through semi-stoppering, spanning, freeze-
drying, introducing
nitrogen, performing
tamponade, taking out the injection from a box, rolling a mouth, passing the quality inspection, and packaging.